People: Allergan Inc (AGN)

AGN on New York Consolidated

29 Jan 2015
Change (% chg)

$0.03 (+0.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Ingram, Douglas 

Brief Biography

Mr. Douglas S. Ingram, Esq., has been appointed as President of Allergan Inc., effective July 1, 2013. He served as Executive Vice President and President, Europe, Africa, Middle East of the Company. With more than 25 years of professional experience, Mr. Ingram has a background in the health care industry, both in the U.S. and internationally. For the past three years, Mr. Ingram has served as Executive Vice President and President, Europe, Africa and Middle East (EAME). In this role, he was responsible for Allergan's regional pharmaceutical and medical device operations, with a focus on strategic planning, sales and marketing, development and general management. Prior to working for the EAME region, Mr. Ingram served as Executive Vice President and Chief Administrative Officer. During Mr. Ingram's tenure in this role, at various times, he led Allergan's Global Legal Affairs, Compliance, Internal Audit and Internal Controls, Human Resources, Regulatory Affairs and Safety, and Global Corporate Affairs and Public Relations departments. Mr. Ingram also served as Allergan's Secretary and Chief Ethics Officer from July 2001 to July 2010. Mr. Ingram joined Allergan in 1996 as Senior Attorney and Chief Litigation Officer and was promoted to Associate General Counsel and Assistant Secretary, and later, to General Counsel. Before joining Allergan in 1996, Mr. Ingram was an attorney with Gibson, Dunn & Crutcher from 1988, practicing in the area of complex commercial litigation. Mr. Ingram graduated magna cum laude with a Bachelor of Science degree from Arizona State University in 1985 and received his Juris Doctorate from the University of Arizona in 1988, graduating summa cum laude and Order of the Coif.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,185,220 -- 2,390,820 3,576,040

Options Compensation

  Quantity Market Value
Exercisable 10,807 6,337,090.00
Unexercisable 99,814 3,570,580.00
Exercised 166,000 7,908,250.00
Name Fiscal Year Total

David Pyott


Douglas Ingram


James Hindman


Scott Whitcup


Arnold Pinkston


Scott Sherman

As Of 30 Dec 2013
Search Stocks